Evolus price target raised to $25 from $23 at Stifel

Stifel raised the firm’s price target on Evolus to $25 from $23 and keeps a Buy rating on the shares. Evolus reiterated “strong” 2024 revenue guidance, representing growth still at multiples of the market, and accelerated expectations of achieving profitability now for Q4 and FY25, despite 2024 being a year of continued execution for account penetration and growth, geographic expansion, continued development and regulatory filings, the analyst tells investors in a post-earnings note.